Insider · CIK 0001914647

Jones Jeffrey Alan

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001914647

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-24	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,582 sh	$14.47	−$66.3K	159,968
2026-02-20	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,982 sh	$13.62	−$67.9K	164,550
2026-02-18	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+300K sh	—	—	300,000
2025-12-18	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,632 sh	$9.67	−$44.8K	169,532
2025-02-25	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,895 sh	$8.53	−$41.8K	174,164
2025-02-19	CGEMCullinan Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+65K sh	—	—	179,059
2025-02-19	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+130K sh	—	—	130,000
2024-12-18	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,632 sh	$11.41	−$52.9K	114,059
2024-02-22	CGEMCullinan Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+62.5K sh	—	—	118,691
2024-02-22	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+125K sh	—	—	125,000
2023-12-21	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,860 sh	$8.50	−$15.8K	56,191
2023-12-18	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−386 sh	$8.22	−$3,172.92	58,051
2023-06-20	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−387 sh	$12.94	−$5,007.78	58,437
2023-05-18	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−394 sh	$8.76	−$3,451.44	58,824
2023-04-18	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−392 sh	$10.71	−$4,198.32	59,218
2023-03-20	CGEMCullinan Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−390 sh	$11.32	−$4,414.8	59,610
2023-02-17	CGEMCullinan Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+60K sh	—	—	60,000
2023-02-17	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+120K sh	—	—	120,000
2022-02-28	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+215K sh	—	—	215,000

Recent filings

Accepted (ET)
Feb 254
Jones Jeffrey Alan0001193125-26-072000
SEC(opens sec.gov)
Feb 234
Jones Jeffrey Alan0001193125-26-064257
SEC(opens sec.gov)
Feb 194
Jones Jeffrey Alan0001193125-26-059640
SEC(opens sec.gov)
Dec 194
Jones Jeffrey Alan0001193125-25-327030
SEC(opens sec.gov)
Feb 274
Jones Jeffrey Alan0000950170-25-029201
SEC(opens sec.gov)
Feb 214
Jones Jeffrey Alan0000950170-25-025028
SEC(opens sec.gov)
Dec 204
Jones Jeffrey Alan0000950170-24-139124
SEC(opens sec.gov)
Feb 234
Jones Jeffrey Alan0000950170-24-019455
SEC(opens sec.gov)
Dec 224
Jones Jeffrey Alan0000950170-23-072756
SEC(opens sec.gov)
Dec 204
Jones Jeffrey Alan0000950170-23-071987
SEC(opens sec.gov)
Jun 214
Jones Jeffrey Alan0000950170-23-029161
SEC(opens sec.gov)
May 194
Jones Jeffrey Alan0000899243-23-013361
SEC(opens sec.gov)
Apr 204
Jones Jeffrey Alan0000950170-23-013705
SEC(opens sec.gov)
Mar 274
Jones Jeffrey Alan0000899243-23-009717
SEC(opens sec.gov)
Feb 214
Jones Jeffrey Alan0000899243-23-005728
SEC(opens sec.gov)
Mar 24
Jones Jeffrey Alan0000899243-22-008730
SEC(opens sec.gov)

Companies

Cullinan Therapeutics, Inc.Chief Medical OfficerCGEM

Address

C/O CULLINAN THERAPEUTICS, INC. ONE MAIN STREET, SUITE 1350

CAMBRIDGE, MA, 02142